To further target precursors required for glucuronidation we administered acarbose, an oral alpha-glucosidase inhibitor used in managing type 2 diabetes mellitus and previously shown to reduce glucose in Drosophila [39]. The gene discussed is GAA; the disease is diabetes mellitus.